Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Proceedings of the signature series symposium “cellular therapies for orthopaedics and musculoskeletal disease proven and unproven therapies—promise, facts and fantasy,” international society for cellular therapies, montreal, canada, may 2, 2018

  • NICOLAS S. Piuzzi
  • , M. DOMINICI
  • , M. A.R.C. LONG
  • , C. PASCUAL-GARRIDO
  • , S. RODEO
  • , J. HUARD
  • , JÉROME GUICHEUX
  • , R. MCFARLAND
  • , LAURIE R. GOODRICH
  • , STÉPHANE MADDENS
  • , PAMELA G. ROBEY
  • , THOMAS W. BAUER
  • , J. O.H.N. BARRETT
  • , F. BARRY
  • , D. KARLI
  • , CONSTANCE R. CHU
  • , DANIEL J. WEISS
  • , I. V.A.N. MARTIN
  • , C. JORGENSEN
  • , GEORGE F. MUSCHLER*
  • *Autor correspondiente de este trabajo
  • Cleveland Clinic Foundation
  • Hospital Italiano de Buenos Aires
  • University of Modena and Reggio Emilia
  • MTF Biologics
  • Washington University St. Louis
  • Hospital for Special Surgery - New York
  • University of Texas Health Science Center at Houston
  • Steadman Philippon Research Institute
  • Inserm
  • Advanced Regenerative Manufacturing Institute
  • Colorado State University
  • Vetbiobank
  • National Institutes of Health
  • National University of Ireland
  • Greyledge Technologies, LLC
  • Stanford University
  • Veterans Affairs Medical Center
  • University of Vermont
  • University of Basel
  • CHU Montpellier

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

36 Citas (Scopus)

Resumen

The Signature Series Symposium “Cellular Therapies for Orthopaedics and Musculoskeletal Disease Proven and Unproven Therapies—Promise, Facts and Fantasy” was held as a pre-meeting of the 26th International Society for Cellular Therapy (ISCT) annual congress in Montreal, Canada, May 2, 2018. This was the first ISCT program that was entirely dedicated to the advancement of cell-based therapies for musculoskeletal diseases. Cellular therapies in musculoskeletal medicine are a source of great promise and opportunity. They are also the source of public controversy, confusion and misinformation. Patients, clinicians, scientists, industry and government share a commitment to clear communication and responsible development of the field. Therefore, this symposium convened thought leaders from around the world in a forum designed to catalyze communication and collaboration to bring the greatest possible innovation and value to patients with musculoskeletal conditions.

Idioma originalInglés
Páginas (desde-hasta)1381-1400
Número de páginas20
PublicaciónCytotherapy
Volumen20
N.º11
DOI
EstadoPublicada - nov. 2018
Publicado de forma externa

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

  1. ODS 3: Salud y bienestar
    ODS 3: Salud y bienestar

Huella

Profundice en los temas de investigación de 'Proceedings of the signature series symposium “cellular therapies for orthopaedics and musculoskeletal disease proven and unproven therapies—promise, facts and fantasy,” international society for cellular therapies, montreal, canada, may 2, 2018'. En conjunto forman una huella única.

Citar esto